The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlating HLA variants and the emergence of immune-related adverse events (irAEs) from ipilimumab/nivolumab (I/N) in patients (pts) treated on CheckMate 214.
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Affimed Therapeutics; AVEO; Calithera Biosciences; Eisai; Exelixis; Genentech; Merck; MicuRx Pharmaceuticals; Oncorena; OnQuality Pharmaceuticals
Research Funding - Pfizer
Other Relationship - BMS
(OPTIONAL) Uncompensated Relationships - Aravive; BMS; Genentech/Roche
 
Neil J. Shah
Consulting or Advisory Role - Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst)
Travel, Accommodations, Expenses - Merck
 
Hannah L Kalvin
No Relationships to Disclose
 
Jayon Lihm
No Relationships to Disclose
 
Hao Li
No Relationships to Disclose
 
Ritesh R Kotecha
Consulting or Advisory Role - Eisai; Eisai
Research Funding - Allogene Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
 
Irene Jarchum
Employment - Bristol Myers Squibb; Immunai
Stock and Other Ownership Interests - Adaptive Biotechnologies; Bristol-Myers Squibb/Celgene
Patents, Royalties, Other Intellectual Property - Holds patents and participates in royalty agreement with Seres Therapeutics (I)
 
Sai Vikram Vemula
Employment - Bristol-Myers Squibb/Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
 
Saurabh Gupta
Employment - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Bristol-Myers Squibb/Celgene (I); Bristol-Myers Squibb/Celgene (I)
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Aveo; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Merck; Pfizer
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Irina Ostrovnaya
No Relationships to Disclose
 
Benjamin Greenbaum
No Relationships to Disclose
 
A. Ari Hakimi
Consulting or Advisory Role - Merck